Silk fibroin sponges have been widely studied and reported in literature for tissue engineering applications. Several fabrication methods have been proposed during the years to cover most of the demands in terms of properties, which should be adapted to the considered tissue. Most of these procedures are based on the secondary structure transition of the protein to the stable β crystalline form. This transition, known as physical cross-linking, makes the sponge resistant to dissolution in water, and, in general, increases the sponge stiffness. In our work, we propose an alternative method to ensure the stability of the sponge based on chemical crosslinking of a methacrylated version of silk fibroin (Sil-MA) obtained via chemical modification. The Sil-MA water solution with the addition of a photoinitiator (LAP) allows the opening, under UV radiation, of a double carbon−carbon bond and radical polymerization. The incorporation of air bubbles (that serves as a template for the pores) was accomplished by a mixer; then, the foam was stabilized under UV light and the excess water was removed by freeze-drying. Because of the cytotoxicity of the photoinitiator (found when used at a high concentration), an additional washing step in water has been introduced to eliminate the residues and improve the cells' viability. Fourier transform infrared (FTIR) analysis confirmed the functionalization of the protein. To evaluate the effect of the composition on the sponge properties, a 2 3 full factorial design of the experiment has been adopted. FTIR analysis revealed that the sponge composition did not affect the protein's secondary structure. The analysis of images obtained by SEM allowed some statistical measures of the porosity curves to be studied and modeled. The same modeling procedure was applied to the dissolution test in a simulated body fluid, to the water absorption, and to the cell viability (tested by the MTT and LDH assays). An empirical model for each property was built, showing how by changing the composition it is possible to tune the sponge properties.

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are used clinically as target therapies for lung cancer patients, but the occurrence of acquired drug resistance limits their efficacy. Nicotinamide N-methyltransferase (NNMT), a cancer-associated metabolic enzyme, is commonly overexpressed in various human tumors. Emerging evidence also suggests a crucial loss of function of microRNAs (miRNAs) in modulating tumor progression in response to standard therapies. However, their precise roles in regulating the development of drug-resistant tumorigenesis are still poorly understood. Herein, we established EGFR-TKI-resistant non-small-cell lung cancer (NSCLC) models and observed a negative correlation between the expression levels of NNMT and miR-449a in tumor cells. Additionally, knockdown of NNMT suppressed p-Akt and tumorigenesis, while re-expression of miR-449a induced phosphatase and tensin homolog (PTEN), and inhibited tumor growth. Furthermore, yuanhuadine, an antitumor agent, significantly upregulated miR-449a levels while critically suppressing NNMT expression. These findings suggest a novel therapeutic approach for overcoming EGFR-TKI resistance to NSCLC treatment.

No abstract

Chemical investigation of a halophilic actinomycete strain belonging to the genus Nocardiopsis inhabiting a hypersaline saltern led to the discovery of new 18-membered macrolides with nitrile functionality, borrelidins C-E (1-3), along with a previously reported borrelidin (4). The planar structures of borrelidins C-E, which are new members of the rare borrelidin class of antibiotics, were elucidated by NMR, mass, IR, and UV spectroscopic analyses. The configurations of borrelidines C-E were determined by the interpretation of ROESY NMR spectra, J-based configuration analysis, a modified Mosher's method, and CD spectroscopic analysis. Borrelidins C and D displayed inhibitory activity, particularly against the Gram-negative pathogen Salmonella enterica, and moderate cytotoxicity against the SNU638 and K562 carcinoma cell lines.

No abstract